Mainz Biomed B.V. (MYNZ) Stock Statistics & Valuation Metrics

Mainz Biomed B.V. has a market cap or net worth of $7.41M. The enterprise value is ―.

Mainz Biomed B.V. has 3,038,853 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mainz Biomed B.V.’s return on equity (ROE) is -8.09 and return on invested capital (ROIC) is -233.79%.

The current PE Ratio of Mainz Biomed B.V. is -28.66. Mainz Biomed B.V.’s PEG ratio is <0.01.

In the last 12 months, Mainz Biomed B.V. had revenue of 895.48K and earned -26.30M in profits. Earnings per share was -1.62.

In the last 12 months, operating cash flow was -12.80M and capital expenditures -382.47K, giving a free cash flow of -13.18M billion.

Mainz Biomed B.V. pays an annual dividend of ―, resulting in a dividend yield of ―

Mainz Biomed B.V. upcoming earnings date is Sep 3, 2025, TBA Not Confirmed.

Mainz Biomed B.V. as a current ratio of 0.97, with Debt / Equity ratio of -199.82%

In the past 12 months, Mainz Biomed B.V. has paid 0.00 in taxes.

Mainz Biomed B.V. EV to EBITDA ratio is -30.15, with an EV/FCF ratio of -31.63.

Mainz Biomed B.V. has $977.76K in cash and marketable securities with $8.27M in debt, giving a net cash position of $7.29M billion.

Gross margin is 48.85%, with operating margin of -2975.47%, and net profit margin of -2936.50%.

The average price target for Mainz Biomed B.V. is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy